Physician
Oncology
Dr. Lorrin K. Yee, MD
|
|
Give Review
Dr. Lorrin K. Yee works in the field of Oncology. He studied medicine at David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a one of the best medicals schools. David Geffen School of Medicine at UCLA is ranked 13 in research and 7 in primary care medicine Lorrin is a published physician. He published 15 publications, including: 'Analysis of the active lactone form of 9-aminocamptothecin in plasma using solid-phase extraction and high-performance liquid chromatography.'
Publications
- Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid Tumors: an open-l...
- TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first-line treatment of metastatic colorectal Cancer: A randomized phase 1b/2 trial.
- Phase I Study of U3-1287, a Fully Human Anti-HER3 Monoclonal Antibody, in Patients with Advanced Solid Tumors.
- Phase 1 first-in-human trial of the vascular disrupting agent plinabulin(NPI-2358) in patients with solid tumors or Lymphomas.
- A phase Ib study of AMG 102 in combination with bevacizumab or motesanib in patients with advanced solid Tumors.
- A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with Anemia who have nonmyelo...
- A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced Anemia in patients with breast, lung, or gyn...
- Analysis of the active lactone form of 9-aminocamptothecin in plasma using solid-phase extraction and high-performance liquid chromatography.
- N-(phosphonacetyl)-L-aspartate and calcium leucovorin modulation of fluorouracil administered by constant rate and circadian pattern of infusion over 72 hours in metas...
- Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting.
- High inter- and intrapatient variation in 5-fluorouracil plasma concentrations during a prolonged drug infusion.
- Effect of the cytochrome P450 2C19 inhibitor omeprazole on the pharmacokinetics and safety profile of bortezomib in patients with advanced solid tumours, non-Hodgkin''...
- Treatment of chemotherapy-induced anemia in breast Cancer: results of a randomized controlled trial of darbepoetin alfa 200 microg every 2 weeks versus epoetin alfa 40...
- Comparison of darbepoetin alfa dosed weekly (QW) vs. extended dosing schedule (EDS) in the treatment of Anemia in patients receiving multicycle chemotherapy in a rando...
Schools
University of California At Los Angeles
UCLA Med Center
University Of Wisconsin Hospital and Clinics
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
National Institutes of Health Clinical Center -
University of Wisconsin -
UCLA Medical Center -
David Geffen School of Medicine at UCLA
Helpful Reviews
Similar Doctors
|
|
Dr. Nicole Grous, MD
 This Doctor is OpenDoctor Recommended.
|